Literature DB >> 28389514

Histopathology of Prostate Cancer.

Peter A Humphrey1.   

Abstract

This review focuses on histopathological aspects of carcinoma of the prostate. A tissue diagnosis of adenocarcinoma is often essential for establishing a diagnosis of prostate cancer, and the foundation for a tissue diagnosis is currently light microscopic examination of hematoxylin and eosin (H&E)-stained tissue sections. Markers detected by immunohistochemistry on tissue sections can support a diagnosis of adenocarcinoma that is primary in the prostate gland or metastatic. Histological variants of carcinoma of the prostate are important for diagnostic recognition of cancer or as clinicopathologic entities that have prognostic and/or therapeutic significance. Histological grading of adenocarcinoma of the prostate, including use of the 2014 International Society of Urological Pathology (ISUP) modified Gleason grades and the new grade groups, is one of the most powerful prognostic indicators for clinically localized prostate cancer, and is one of the most critical factors in determination of management of these patients.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28389514      PMCID: PMC5629988          DOI: 10.1101/cshperspect.a030411

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  158 in total

1.  Perineural invasion, mucinous fibroplasia, and glomerulations: diagnostic features of limited cancer on prostate needle biopsy.

Authors:  B L Baisden; H Kahane; J I Epstein
Journal:  Am J Surg Pathol       Date:  1999-08       Impact factor: 6.394

2.  The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system.

Authors:  C C Pan; S R Potter; A W Partin; J I Epstein
Journal:  Am J Surg Pathol       Date:  2000-04       Impact factor: 6.394

3.  Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist.

Authors:  W C Allsbrook; K A Mangold; M H Johnson; R B Lane; C G Lane; J I Epstein
Journal:  Hum Pathol       Date:  2001-01       Impact factor: 3.466

4.  Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists.

Authors:  W C Allsbrook; K A Mangold; M H Johnson; R B Lane; C G Lane; M B Amin; D G Bostwick; P A Humphrey; E C Jones; V E Reuter; W Sakr; I A Sesterhenn; P Troncoso; T M Wheeler; J I Epstein
Journal:  Hum Pathol       Date:  2001-01       Impact factor: 3.466

5.  Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy.

Authors:  A W Levi; J I Epstein
Journal:  Am J Surg Pathol       Date:  2000-08       Impact factor: 6.394

6.  Identification of differentially expressed genes in human prostate cancer using subtraction and microarray.

Authors:  J Xu; J A Stolk; X Zhang; S J Silva; R L Houghton; M Matsumura; T S Vedvick; K B Leslie; R Badaro; S G Reed
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

7.  Biological determinants of cancer progression in men with prostate cancer.

Authors:  T A Stamey; J E McNeal; C M Yemoto; B M Sigal; I M Johnstone
Journal:  JAMA       Date:  1999-04-21       Impact factor: 56.272

8.  Diagnosis of prostate cancer in needle biopsies after radiation therapy.

Authors:  L Cheng; J C Cheville; D G Bostwick
Journal:  Am J Surg Pathol       Date:  1999-10       Impact factor: 6.394

9.  Mucin-producing carcinoma of the prostate: review of 88 cases.

Authors:  S Saito; H Iwaki
Journal:  Urology       Date:  1999-07       Impact factor: 2.649

10.  Prostatic foamy gland carcinoma with aggressive behavior: clinicopathologic, immunohistochemical, and ultrastructural analysis.

Authors:  T T Tran; E Sengupta; X J Yang
Journal:  Am J Surg Pathol       Date:  2001-05       Impact factor: 6.394

View more
  26 in total

1.  Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavorable intermediate and high-risk prostate cancer.

Authors:  John Campaña; Patricia Bernal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-04       Impact factor: 9.236

2.  Inhibiting the P2X4 Receptor Suppresses Prostate Cancer Growth In Vitro and In Vivo, Suggesting a Potential Clinical Target.

Authors:  Jiepei He; Yuhan Zhou; Hector M Arredondo Carrera; Alexandria Sprules; Ramona Neagu; Sayyed Amin Zarkesh; Colby Eaton; Jian Luo; Alison Gartland; Ning Wang
Journal:  Cells       Date:  2020-11-20       Impact factor: 6.600

3.  Carcinosarcoma prostate with osteosarcomatous differentiation: a rare de novo presentation.

Authors:  Sumeet Aggarwal; Swarupa Mitra; Abhinav Dewan; Garima Durga
Journal:  BMJ Case Rep       Date:  2019-06-12

4.  Patient with prostatic adenocarcinoma with plasmacytoid features and an aberrant immunohistochemical phenotype diagnosed by biopsy and a mini-review of plasmacytoid features in the genitourinary system: A case report.

Authors:  Konstantina Zacharouli; Dimitra P Vageli; George K Koukoulis; Maria Ioannou
Journal:  Mol Clin Oncol       Date:  2022-01-20

Review 5.  Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance.

Authors:  Maria Destouni; Andreas C Lazaris; Vasiliki Tzelepi
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

6.  Histopathological Study of the Prostate Cancer Growth Patterns in Relation with the Grading Systems.

Authors:  Tudor Cristian Timotei Popescu; Alex Emilian Stepan; Mirela Marinela Florescu; Cristiana Eugenia Simionescu
Journal:  Curr Health Sci J       Date:  2022-03-31

7.  MetaNetwork Enhances Biological Insights from Quantitative Proteomics Differences by Combining Clustering and Enrichment Analyses.

Authors:  Austin V Carr; Brian L Frey; Mark Scalf; Anthony J Cesnik; Zach Rolfs; Kyndal A Pike; Bing Yang; Mark P Keller; David F Jarrard; Michael R Shortreed; Lloyd M Smith
Journal:  J Proteome Res       Date:  2022-01-24       Impact factor: 5.370

8.  3D Registration of pre-surgical prostate MRI and histopathology images via super-resolution volume reconstruction.

Authors:  Rewa R Sood; Wei Shao; Christian Kunder; Nikola C Teslovich; Jeffrey B Wang; Simon J C Soerensen; Nikhil Madhuripan; Anugayathri Jawahar; James D Brooks; Pejman Ghanouni; Richard E Fan; Geoffrey A Sonn; Mirabela Rusu
Journal:  Med Image Anal       Date:  2021-01-23       Impact factor: 8.545

9.  Expression and Clinical Significance of HKII and HIF-1α in Grade Groups of Prostate Cancer.

Authors:  Xueqi Sun; Qirui Huang; Fang Peng; Jian Wang; Weidong Zhao; Guangxiu Guo
Journal:  Front Genet       Date:  2021-06-17       Impact factor: 4.599

Review 10.  Prostate cancer cell heterogeneity and plasticity: Insights from studies of genetically-engineered mouse models.

Authors:  Weiping Li; Michael M Shen
Journal:  Semin Cancer Biol       Date:  2021-06-18       Impact factor: 17.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.